Healthcare -
Biotechnology - NASDAQ - US
$ 7.12
-1.93 %
$ 260 M
Market Cap
-2.27
P/E
ITOS - COST OF REVENUE
Cost of Revenue ITOS - iTeos Therapeutics, Inc.
898 K
LAST VALUE
20.84%
2 YEAR CAGR
12.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR